Lista de obras - Massimiliano Fabbiani - Dominio Público Uruguay

Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice

scientific article published on 10 July 2020

Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility

artículo científico publicado en 2014

Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy

artículo científico publicado en 2010

Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients

artículo científico publicado en 2014

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

artículo científico publicado en 2017

Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study

artículo científico publicado en 2015

Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients

article

Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection.

artículo científico publicado en 2010

Cognitive reserve and neuropsychological functioning in older HIV-infected people.

artículo científico publicado en 2016

Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping

artículo científico publicado en 2010

Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time

artículo científico publicado en 2010

Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients.

artículo científico publicado en 2013

Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: Potential role for an unexpected drug interaction

scientific article published on 02 December 2010

Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data

artículo científico publicado en 2014

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.

artículo científico publicado en 2011

Effect of aging and human immunodeficiency virus infection on cognitive abilities

artículo científico publicado en 2012

Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study.

artículo científico publicado en 2015

Epidemiological and clinical study of viral respiratory tract infections in children from Italy.

artículo científico publicado en 2009

Evaluation and Optimization of an ELISA Procedure to Quantify Antibodies Against Pneumococcal Polysaccharides Included in the 13-Valent Conjugate Vaccine.

artículo científico publicado en 2015

Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance.

artículo científico publicado en 2013

Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial

artículo científico publicado en 2017

Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies

scientific article published on 10 August 2020

HIV-infected patients show impaired cellular immune response to influenza vaccination compared to healthy subjects

artículo científico publicado en 2013

Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients

scientific article published on 07 July 2019

High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

scientific article published on 11 December 2020

Human bocavirus detection in an atopic child affected by pneumonia associated with wheezing

artículo científico publicado en 2007

Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients

article

Immune response to influenza A(H1N1)v in HIV-infected patients

artículo científico publicado en 2014

Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study

artículo científico publicado en 2016

Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20-year retrospective study.

artículo científico publicado en 2009

Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.

artículo científico publicado en 2012

Initial antifungal strategy does not correlate with mortality in patients with candidemia.

artículo científico publicado en 2015

Is There a Drug–Drug Interaction Between Darunavir/Ritonavir and Raltegravir?

artículo científico publicado en 2012

Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients

artículo científico publicado en 2016

Lipid-lowering effect of tenofovir in HIV-infected patients

article

Liver fibrosis is associated with cognitive impairment in HIV-positive patients

artículo científico publicado en 2014

Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection

artículo científico publicado en 2010

Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy

article

Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy

article

Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).

artículo científico publicado en 2016

Ophthalmic artery resistance index is increased in HIV-Infected patients and is influenced by protease inhibitors exposure

article

Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice

artículo científico publicado en 2009

Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis

artículo científico publicado en 2014

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

artículo científico publicado en 2012

Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk

artículo científico publicado en 2014

Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy

artículo científico publicado en 2011

Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen.

artículo científico publicado en 2015

Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients

scientific article published on 03 September 2019

Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure

article

Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection.

artículo científico publicado en 2015

Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model?

artículo científico publicado en 2015

Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia

artículo científico publicado en 2013

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART

artículo científico publicado en 2015

Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events

artículo científico publicado en 2013

Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazana

artículo científico publicado en 2013

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial

artículo científico publicado en 2014

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

artículo científico publicado en 2014

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

artículo científico publicado en 2014

Single-tablet regimen is associated with reduced efavirenz withdrawal in antiretroviral naïve or switching for simplification HIV-infected patients

article

Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study

artículo científico publicado en 2014

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort

artículo científico publicado en 2015

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis

artículo científico publicado en 2014

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study

artículo científico publicado en 2016

Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre.

artículo científico publicado en 2014

Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients

artículo científico publicado en 2011

The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak

artículo científico publicado en 2020

The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy

artículo científico publicado en 2011

The threshold bootstrap clustering: a new approach to find families or transmission clusters within molecular quasispecies

artículo científico publicado en 2010

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).

artículo científico publicado en 2017

Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors

artículo científico publicado en 2015

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

artículo científico publicado en 2017

Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009.

artículo científico publicado en 2011

Validation of an UPLC-MS/MS method for quantitative analysis of raltegravir in human plasma samples

artículo científico publicado en 2013

Variability of raltegravir plasma levels in the clinical setting

artículo científico publicado en 2013

Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS.

artículo científico publicado en 2016

Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy

artículo científico publicado en 2016

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received

artículo científico publicado en 2012

[Retrospective study of tuberculosis in the Province of Siena]

artículo científico publicado en 2005

Lista de obras de Massimiliano Fabbiani

Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice

Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility

Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy

Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study

Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients

Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection.

Cognitive reserve and neuropsychological functioning in older HIV-infected people.

Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping

Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time

Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients.

Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: Potential role for an unexpected drug interaction

Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.

Effect of aging and human immunodeficiency virus infection on cognitive abilities

Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study.

Epidemiological and clinical study of viral respiratory tract infections in children from Italy.

Evaluation and Optimization of an ELISA Procedure to Quantify Antibodies Against Pneumococcal Polysaccharides Included in the 13-Valent Conjugate Vaccine.

Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance.

Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial

Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies

HIV-infected patients show impaired cellular immune response to influenza vaccination compared to healthy subjects

Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients

High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

Human bocavirus detection in an atopic child affected by pneumonia associated with wheezing

Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients

Immune response to influenza A(H1N1)v in HIV-infected patients

Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study

Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20-year retrospective study.

Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.

Initial antifungal strategy does not correlate with mortality in patients with candidemia.

Is There a Drug–Drug Interaction Between Darunavir/Ritonavir and Raltegravir?

Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients

Lipid-lowering effect of tenofovir in HIV-infected patients

Liver fibrosis is associated with cognitive impairment in HIV-positive patients

Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection

Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy

Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy

Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).

Ophthalmic artery resistance index is increased in HIV-Infected patients and is influenced by protease inhibitors exposure

Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice

Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk

Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy

Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen.

Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients

Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure

Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection.

Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model?

Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART

Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events

Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazana

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

Single-tablet regimen is associated with reduced efavirenz withdrawal in antiretroviral naïve or switching for simplification HIV-infected patients

Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study

Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre.

Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients

The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak

The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy

The threshold bootstrap clustering: a new approach to find families or transmission clusters within molecular quasispecies

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).

Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009.

Validation of an UPLC-MS/MS method for quantitative analysis of raltegravir in human plasma samples

Variability of raltegravir plasma levels in the clinical setting

Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS.

Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received

[Retrospective study of tuberculosis in the Province of Siena]